• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; INSERT, TUBAL OCCLUSION Back to Search Results
Model Number ESS305
Device Problem Insufficient Information (3190)
Patient Problems Asthma (1726); Dyspnea (1816); Fatigue (1849); Headache (1880); Unspecified Infection (1930); Pain (1994); Tinnitus (2103); Burning Sensation (2146)
Event Type  Injury  
Event Description
This case was initially received via regulatory authority ansm (reference number: (b)(4)) on 29-sep-2017.This spontaneous case was reported by a consumer and describes the occurrence of pelvic pain ("pelvic pains") in a female patient who had essure (batch no.C26933) inserted.The occurrence of additional non-serious events is detailed below.On (b)(6) 2014, the patient had essure inserted.On an unknown date, the patient experienced pelvic pain (seriousness criteria medically significant and intervention required), tinnitus ("tinnitus"), fatigue ("fatigue"), dyspnoea ("out of breath"), dyspepsia ("digestive disorders"), allergy to metals ("titanium and nickel allergy"), eczema ("eczema"), burning sensation ("burning"), cystitis ("cystitis"), fungal infection ("mycosis"), headache ("headaches") and asthma ("asthma").The patient was treated with surgery (removal of essure was planned).Essure treatment was not changed.At the time of the report, the pelvic pain, tinnitus, fatigue, dyspnoea, dyspepsia, allergy to metals, eczema, burning sensation, cystitis, fungal infection, headache and asthma outcome was unknown.The reporter provided no causality assessment for allergy to metals, asthma, burning sensation, cystitis, dyspepsia, dyspnoea, eczema, fatigue, fungal infection, headache, pelvic pain and tinnitus with essure.The reporter commented: the event happened at the home of the patient.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on (b)(6) 2017: quality safety evaluation of ptc.The list of device similar incidents contains essure reports received by bayer and older cases received by conceptus coded with the same medra preferred term.In this particular case a search in the database was performed on (b)(6) 2017 for the following meddra preferred term: pelvic pain.The analysis in the global safety database revealed (b)(4) cases.Bayer is closely monitoring the benefit-risk profile of essure.A recent cumulative review of all available data on essure has not yielded any new safety signal with regard to this meddra pt.Further company follow-up with the regulatory authority is not possible.Incident: at the time of reporting, there is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
INSERT, TUBAL OCCLUSION
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin 13353
GM   13353
Manufacturer Contact
k. lamberson
100 bayer blvd.
p.o. box 915
whippany 07981-0915
MDR Report Key6982881
MDR Text Key90395225
Report Number2951250-2017-05517
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 10/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2017
Device Model NumberESS305
Device Lot NumberC26933
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-